Cytochrome P450 2C19 Polymorphism in Young Post-Myocardial Infarction Patients Treated With Clopidogrel

被引：0
|
作者：
Collet, Jean-Philippe
Hulot, Jean-Sebastien
Pena, Ana
Villard, Eric
Esteve, Jean-Baptiste
Silvain, Johanne
Payot, Laurent
Cayla, Guillaume
Beygui, Farzin
Brugier, Delphine
Funck-Brentano, Christian
Montalescot, Gilles
机构：
[1] Hop La Pitie Salpetriere, Inst Cardiol, Paris, France
[2] Hop La Pitie Salpetriere, Pharmacol Unit, Paris, France
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2009年 / 53卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A344 / A344
页数：1
相关论文
共 50 条
  • [21] Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
    Zeruesenay Desta
    Xiaojiong Zhao
    Jae-Gook Shin
    David A. Flockhart
    Clinical Pharmacokinetics, 2002, 41 : 913 - 958
  • [22] Cytochrome P450 2C19 polymorphism in Iranian patients with coronary artery disease
    Akhlaghi, Arash
    Shirani, Shahin
    Ziaie, Naghmeh
    Pirhaji, Omid
    Yaran, Majid
    Shahverdi, Golnoosh
    Sarrafzadegan, Nizal
    Khosravi, Alireza
    Khosravi, Elham
    ARYA ATHEROSCLEROSIS, 2011, 7 (03) : 106 - 110
  • [23] Impact of the cytochrome P450 2C19*3 polymorphism on platelet reactivity and adverse clinical events in patients with acute myocardial infarction
    Jeong, Y. H.
    Tantry, U. T.
    Jung, T. J.
    Park, Y. H.
    Kim, I. S.
    Bliden, K. A.
    Gurbel, P. A.
    EUROPEAN HEART JOURNAL, 2011, 32 : 508 - 508
  • [24] Impact of the cytochrome P450 2C19*3 polymorphism on platelet reactivity and adverse clinical events in patients with acute myocardial infarction
    Jeong, Y-H
    Koh, J-S
    Kwon, T. J.
    Park, Y.
    Kim, I-S
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 793 - 793
  • [25] The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro
    Xu, Ren-ai
    Gu, Er-min
    Liu, Teng-hui
    Ou-yang, Qiu-geng
    Hu, Guo-xin
    Cai, Jian-ping
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 2129 - 2135
  • [26] Switching from prasugrel to clopidogrel based on Cytochrome P450 2C19 genotyping in East Asian patients stabilized after acute myocardial infarction
    Lee, Ji Hyun
    Ahn, Sung Gyun
    Lee, Jun-Won
    Youn, Young Jin
    Ahn, Min-Soo
    Kim, Jang-Young
    Yoo, Byung-Su
    Lee, Seung-Hwan
    Yoon, Junghan
    Kim, Juwon
    Choi, Eunhee
    Yoo, Sang-Yong
    Hung, Olivia Y.
    Samady, Habib
    PLATELETS, 2016, 27 (04) : 301 - 307
  • [27] THE SINGLE NUCLEOTIDE POLYMORPHISMS (SNPs) ASSOCIATED WITH CYTOCHROME P450 2C19 IN PATIENTS ON CLOPIDOGREL THERAPY
    Nazarene, A.
    Chandar, C. S. Ravi
    Kumar, A. M.
    Nagarajan, B.
    Govindarajan, S. R.
    Ranganathan, L. N.
    S, G.
    INTERNATIONAL JOURNAL OF STROKE, 2016, 11 (SUPP 3) : 113 - 113
  • [28] Human Cytochromes P450: Focus on Cytochrome P450 2C19
    Zvyaga, Tatyana
    Chang, Shu-Ying
    Chen, Cliff
    Yang, Zheng
    Vuppugalla, Ragini
    Hurley, Jeremy
    Thorndike, Denise
    Wagner, Andrew
    Chimalakonda, Anjaneya
    Rodrigues, A. David
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (09) : 1698 - 1711
  • [29] Efficacy and Adverse Events of Clopidogrel and Ticagrelor in Patients with Cytochrome P450 2C19 Gene Deletion
    Cai, Xiaofang
    Jiang, S. J.
    Chen, Jiana
    Cai, Xiujuan
    Wang, W. L.
    Huang, J. D.
    Zhang, J. H.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 : 175 - 181
  • [30] Genetic Polymorphisms of Cytochrome P450 2C19 in Functional Dyspeptic Patients Treated with Cimetidine
    Kim, Minhee
    Kong, Eunhee
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2012, 16 (05): : 339 - 342
12345